Neuphoria Therapeutics NEUP
NASDAQ NEUP
$2.71 +0.02 (+0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Neuphoria Therapeutics (NEUP) EBT Margin (2024 - 2025)

Updated

Neuphoria Therapeutics (NEUP) posted EBT Margin of -1157.51% for FY2026 (year ended Jun 30, 2026), down 1152.16 percentage points from -5.35% in FY2025.

Analysis

Neuphoria Therapeutics (NEUP) EBT Margin (2024 - 2025) Analysis & Trends

Since FY2020, Neuphoria Therapeutics has reported EBT Margin for 5 fiscal years.

  • Annual EBT Margin shows a four-year change of +7168.87 percentage points (FY2022 to FY2026).
  • The FY2026 figure stands as the lowest annual EBT Margin since FY2023.
  • Business Quant data shows NEUP's EBT Margin at -5.35% in FY2025, -146049.21% in FY2023 (-137722.83 pp) and -8326.38% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.13%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 27.75%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 26.27%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 45.21%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.90%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 20.41%
10 Neuphoria Therapeutics 335.34 Mn 260.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 74.54%
Dec 31, 2024 -291.49%
API Access

Neuphoria Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NEUP&period=max&api_key=YOUR_API_KEY